From Surrogacy to the ART Act: How India’s Fertility Regulations Are Reshaping Reproductive Medicine
The rapid growth of assisted reproductive technologies over the past three decades has transformed fertility care in India. Alongside remarkable scientific advances, however, policymakers have faced increasingly complex ethical, legal and regulatory questions surrounding IVF, surrogacy and reproductive medicine.
The introduction of the Assisted Reproductive Technology (Regulation) Act and the Surrogacy (Regulation) Act marked a significant shift in India’s approach to fertility governance. Together, these laws seek to establish greater transparency, accountability and patient protection while creating a formal regulatory framework for fertility clinics and reproductive services.
Prior to these legislative reforms, India’s fertility sector expanded largely through professional guidelines and voluntary standards developed by medical organisations. While many clinics maintained high clinical standards, variations in practice highlighted the need for uniform regulation.
Legal experts note that the new framework introduces mandatory registration of fertility clinics and ART banks, establishes documentation requirements and strengthens oversight mechanisms intended to improve patient safety.
Medical professionals broadly agree that regulation has become increasingly important as reproductive technologies have grown more sophisticated. Treatments now frequently involve advanced embryology, donor programmes, fertility preservation and genetic testing, requiring robust governance alongside scientific innovation.
Senior fertility specialists have participated in policy discussions over many years, providing clinical perspectives during consultations and academic forums. Among them is Dr. Hrishikesh Pai, who has been associated with professional organisations involved in advancing reproductive medicine and encouraging evidence-based clinical standards.
Experts emphasise that regulation should not be viewed solely through a legal lens. It also supports quality assurance by encouraging consistent documentation, laboratory standards and ethical patient care. As fertility treatment becomes increasingly complex, transparent clinical governance benefits both healthcare providers and patients.
At the same time, implementation continues to present practical challenges. Fertility clinics have needed to adapt operational processes, documentation systems and compliance procedures to meet evolving regulatory expectations. Smaller centres, in particular, face the task of balancing regulatory compliance with accessibility and affordability.
Legal scholars also highlight the importance of continued dialogue between policymakers, clinicians, embryologists and patient advocacy groups. Reproductive medicine evolves rapidly, and regulatory frameworks must remain responsive to scientific advances while safeguarding ethical principles.
The conversation extends beyond legislation alone. Advances such as fertility preservation, reproductive genetics and artificial intelligence-assisted embryo assessment will likely raise new regulatory questions in the coming years. Policymakers and clinicians will need to work collaboratively to ensure innovation proceeds responsibly.
Public awareness has also become an increasingly important component of fertility regulation. Specialists emphasise informed consent, realistic patient expectations and comprehensive counselling as essential aspects of ethical reproductive care. Regulation reinforces these principles by encouraging transparency throughout the treatment journey.
Healthcare researchers argue that India’s regulatory evolution reflects the maturity of its fertility ecosystem. The focus has gradually shifted from simply expanding access to ensuring quality, accountability and long-term sustainability.
As reproductive medicine continues to evolve, legislation such as the ART Act provides an institutional framework that complements scientific progress. Within this broader story, experienced clinicians—including Dr. Hrishikesh Pai—represent one of many professional voices contributing to the development of responsible, patient-centred fertility care in India.
